cardioP Cancer Research Results
cardioP, cardioProtective: Click to Expand ⟱
| Source: |
| Type: |
CardioProtective
|
Lung, Lung Cancer: Click to Expand ⟱
Lung CSC (Cancer Stem Cells) markers (CD133, CD44, ALDHA1, Nanog and Oct4)
|
Scientific Papers found: Click to Expand⟱
*cardioP↑, *Inflam↓, BioAv↑, TNF-α↓, MIP‑1α/CCL3↓, GranB/GZMB↓,
BioAv↑, toxicity↝, Ki-67↓, miR-106b↓, chemoPv↑, Dose↝, miR-19b↓, PTEN↑, IGF-2R↑, p‑Akt↓, PGE2↓, PGI2↓, COX2/PTGS2↓, Apoptosis↑, TumCP↓, Inflam↓, cardioP↑,
| - |
in-vitro, |
Liver, |
HepG2 |
|
|
|
- |
in-vitro, |
CRC, |
HT-29 |
|
|
|
- |
in-vitro, |
Lung, |
A549 |
|
|
|
ChemoSen↑, TumCP↓, chemoP↑, *ROS↓, *mtDam↓, *Apoptosis↓, *cardioP↑, *NRF2↑, *TGF-β↑, *p‑JNK↓, *p‑p38↓, *MAPK↝, *Akt↝, *STAT3↝,
Showing Research Papers: 1 to 3 of 3
* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 3
Pathway results for Effect on Cancer / Diseased Cells:
NA, unassigned(tgid=0) ⓘ
IGF-2R↑, 1, miR-106b↓, 1, PGI2↓, 1,
Cell Death(tgid=5) ⓘ
p‑Akt↓, 1, Apoptosis↑, 1, GranB/GZMB↓, 1,
Proliferation, Differentiation & Cell State(tgid=12) ⓘ
PTEN↑, 1,
Migration(tgid=13) ⓘ
Ki-67↓, 1, miR-19b↓, 1, TumCP↓, 2,
Immune & Inflammatory Signaling(tgid=16) ⓘ
COX2/PTGS2↓, 1, Inflam↓, 1, MIP‑1α/CCL3↓, 1, PGE2↓, 1, TNF-α↓, 1,
Drug Metabolism & Resistance(tgid=21) ⓘ
BioAv↑, 2, ChemoSen↑, 1, Dose↝, 1,
Clinical Biomarkers(tgid=22) ⓘ
Ki-67↓, 1,
Functional Outcomes(tgid=23) ⓘ
cardioP↑, 1, chemoP↑, 1, chemoPv↑, 1, toxicity↝, 1,
Total Targets: 23
Pathway results for Effect on Normal Cells:
Redox & Oxidative Stress(tgid=1) ⓘ
NRF2↑, 1, ROS↓, 1,
Mitochondria & Bioenergetics(tgid=3) ⓘ
mtDam↓, 1,
Cell Death(tgid=5) ⓘ
Akt↝, 1, Apoptosis↓, 1, p‑JNK↓, 1, MAPK↝, 1, p‑p38↓, 1,
Proliferation, Differentiation & Cell State(tgid=12) ⓘ
STAT3↝, 1,
Migration(tgid=13) ⓘ
TGF-β↑, 1,
Immune & Inflammatory Signaling(tgid=16) ⓘ
Inflam↓, 1,
Functional Outcomes(tgid=23) ⓘ
cardioP↑, 2,
Total Targets: 12
Scientific Paper Hit Count for: cardioP, cardioProtective
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include :
-low or high Dose
-format for product, such as nano of lipid formations
-different cell line effects
-synergies with other products
-if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:15 Cells:% prod#:% Target#:1188 State#:% Dir#:2
wNotes=0 sortOrder:rid,rpid
Home Page